Sorafenib Completed Phase 2 Trials for Malignant Neoplasm of Stomach / Effects of Chemotherapy Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01187212Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation